UBS Group
WGBS

UBS Group’s WaferGen Bio-systems, Inc. WGBS Stock Holding History

UBS Group’s Portfolio WGBS Stock Details WGBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,287
Closed -$31K – 8358
2016
Q4 		$31K Buy
6,287
+4,235
+206% +$18.6K ﹤0.01% 6225
2016
Q3 		$9K Sell
2,052
-9,184
-82% -$41.1K ﹤0.01% 6882
2016
Q2 		$46K Buy
11,236
+5,152
+85% +$19.2K ﹤0.01% 5591
2016
Q1 		$20K Buy
6,084
+6,083
+608,300% +$19.5K ﹤0.01% 6218
2015
Q4 		$0 Sell
1
-1,699
-100% -$8.43K ﹤0.01% 8779
2015
Q3 		$12K Buy
1,700
+1,699
+169,900% +$15.6K ﹤0.01% 7170
2015
Q2 		$0 Hold
1
– – ﹤0.01% 9130
2015
Q1 		$0 Hold
1
– – ﹤0.01% 9829
2014
Q4 		$0 Buy
+1
New +$19 ﹤0.01% 9712

UBS Group's WGBS Position: Q1 2017 in Review

UBS Group sold out of WaferGen Bio-systems, Inc. (WGBS) in Q1 2017, closing a stake of 6,287 shares — an estimated $31K sold.

UBS Group first reported a position in WGBS in Q4 2014 and held it in 9 quarters. The position peaked at $46K in Q2 2016. 0 funds tracked by Wall St. Rank hold WGBS as of Q1 2017.

  • UBS Group reported no remaining WaferGen Bio-systems, Inc. position as of Q1 2017 after selling out during the quarter.
  • UBS Group sold 6,287 WaferGen Bio-systems, Inc. shares in Q1 2017, an estimated $31K.
  • UBS Group first reported a position in WaferGen Bio-systems, Inc. in Q4 2014 and held it in 9 quarters.
  • UBS Group's WaferGen Bio-systems, Inc. position peaked at $46K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held WaferGen Bio-systems, Inc. as of Q1 2017.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.